Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

Elizabeth A. Ashley, Francesca Aweeka, Karen I. Barnes, Quique Bassat, Steffen Borrmann, Prabin Dahal, Timothy M.E. Davis, Philippe Deloron, Mey Bouth Denis, Abdoulaye A. Djimde, Jean François Faucher, Blaise Genton, Philippe J. Guérin, Kamal Hamed, Eva Maria Hodel, Liusheng Huang, Vincent Jullien, Harin A. Karunajeewa, Jean René Kiechel, Poul Erik KofoedGilbert Lefèvre, Niklas Lindegardh, Kevin Marsh, Andreas Mårtensson, Mayfong Mayxay, Rose McGready, Clarissa Moreira, Paul N. Newton, Billy E. Ngasala, Francois Nosten, Christian Nsanzabana, Sunil Parikh, Ric N. Price, Pascal Ringwald, Lars Rombo, Birgit Schramm, Carol Hopkins Sibley, Kasia Stepniewska, Johan Ursing, Michele Van Vugt, Nicholas J. White, Lesley J. Workman, WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group, WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group

    Research output: Contribution to journalArticlepeer-review

    7 Downloads (Pure)

    Fingerprint Dive into the research topics of 'Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data'. Together they form a unique fingerprint.

    Medicine & Life Sciences